References
- Pierard-Franchimont C, Hermanns JH, Degreef H, Pierard GE, From axioms to new insights into dandruff. Dermatol- ogy (2000) 200: 93–8.
- Loden M, Wessman C, The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo. Int J Cosmet Sci (2000) 22: 285–9.
- Hay RJ, Graham-Brown RAC, Dandruff and seborrheic der- matitis: causes and management. Clin Exp Dermatol (1997) 22: 3–6.
- Aron-Brunetiere R, Dompmartin D, Drouhet E, Treatment of pityriasis capitis (dandruff) with econazole nitrate. Acta Derm Venereol (1977) 57: 77–80.
- Danby FW, Stuart WM, Margesson LJ, Rosenthal D, A ran- domized, double-blind, placebo-controlled trial of ketocona- zole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol (1993) 29: 1008–12.
- Peter RU, Richarz-Barthauer U, Successful treatment and prophylaxis of scalp seborrheic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol (1995) 132: 441–5.
- Dupuy P, Maurette C, Amoric JC et al, Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrheic der- matitis. Br J Dermatol (2001) 1033–7.
- Gupta AK, Ciclopirox: an overview. Int J Dermatol (2001) 40: 305–10.
- Baroni A, De Rosa R, De Rosa A et al, New strategies in dandruff treatment: growth control of Malassezia ovalis. Dermatology (2000) 201: 332–6.
- Bulmer AC, Glenn S, The antifungal action of dandruff shampoos. Mycologica (1999) 147: 63–5.
- Shuster S, The aetiology of dandruff and mode of action of therapeutic agents. Br J Dermatol (1984) 111: 135–42.
- Gupta AK, Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. J Am Acad Dermatol (2000) 43: s81–s95.
- Abrams BB, Hanel H, Hoehler T, Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin Dermatol (1991) 9: 471–7.
- Yu B, Zhou G, Wang B et al, A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis. Chim Med Sci J (1991) 6: 166–8.
- Sehgal VN, Ciclopirox: a new topical pyridonium antimy- cotic agent. A double-blind study in superficial dermatomy- coses. Br J Dermatol (1976) 95: 83–8.
- Lassus A, Nolting KS, Savopoulos C, Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydroxy- cortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clin Ther (1988) 10: 594–9.
- Oliveri S, Cammarata E, Cappello G et al, Ciclopirox olamine: clinical and microbiological considerations. Pre- liminary data. Chemioterapia (1986) 5: 23–5.
- Jue SG, Dawson GW, Brogden RN, Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs (1985) 29: 330–41.
- Rosen T, Schell BJ, Orengo I, Anti-inflammatory activity of antifungal preparations. Int J Dermatol (1997) 36: 788–92.